Prevalence of Functional Gastrointestinal Disorders According to Rome III Criteria in Italian Morbidly Obese Patients

Overview

Journal ScientificWorldJournal

Publisher Wiley

Specialty Biology

Date 2013 Dec 5

PMID 24302861

Citations 10

Authors

Antonella Santonicola

Luigi Angrisani

Carolina Ciacci

Paola Iovino

Affiliations

Soon will be listed here.

Abstract

Unlabelled: The relationship between GI symptoms and obesity has yet to be completely clarified.

Aim: To determine in a morbidly obese southern Italy adult population the prevalence of Functional Gastrointestinal Disorders (FGID) and its association with the presence of a Binge Eating (BE) behavior pattern.

Methods: Consecutive obese patients eligible for bariatric surgery and 100 Healthy Controls (HC) were recruited. All participants were questioned and scored for the presence of FGID according to Rome III criteria and for the presence or the frequency-intensity of a number of upper and lower GI symptoms. BE behavior pattern was assessed.

Results: One-hundred obese patients met the inclusion criteria. The prevalence of FGID was similar between obese patients and HC. There was a significant association between obese patients with BE behavior and postprandial distress syndrome (P = 0.04). Moreover, a significantly higher frequency-intensity score for epigastric fullness (1.23 ± 0.45 versus 0.35 ± 0.13, P = 0.01) was found in obese patients with BE behavior compared to obese patients without.

Conclusions: Obese patients with a BE behavior pattern showed a significantly higher prevalence of postprandial distress syndrome. A greater knowledge of the GI symptoms associated with obesity along with the pathophysiological mechanisms underlying will be important in the clinical management of these patients.

Citing Articles

Functional Gastrointestinal Disorders and Abdominal Visceral Fat in Children and Adolescents.

Kim C, Hyun J, Ryoo E Pediatr Gastroenterol Hepatol Nutr. 2023; 26(6):338-345.

PMID: 38025491 PMC: 10651365. DOI: 10.5223/pghn.2023.26.6.338.

Discovery of Drug Candidates for Specific Human Disease Based on Natural Products of Gut Microbes.

Wang C, Wen Q, Wang Q, Kuang X, Dong C, Deng Z Front Microbiol. 2022; 13:896740.

PMID: 35783383 PMC: 9240467. DOI: 10.3389/fmicb.2022.896740.

Anhedonia and functional dyspepsia in obese patients: Relationship with binge eating behaviour.

Santonicola A, Gagliardi M, Asparago G, Carpinelli L, Angrisani L, Iovino P World J Gastroenterol. 2020; 26(20):2632-2644.

PMID: 32523316 PMC: 7265144. DOI: 10.3748/wjg.v26.i20.2632.

Eating Disorders and Gastrointestinal Diseases.

Santonicola A, Gagliardi M, Guarino M, Siniscalchi M, Ciacci C, Iovino P Nutrients. 2019; 11(12).

PMID: 31842421 PMC: 6950592. DOI: 10.3390/nu11123038.

Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study.

Aasbrenn M, Hogestol I, Eribe I, Kristinsson J, Lydersen S, Mala T BMC Obes. 2017; 4:22.

PMID: 28680646 PMC: 5490229. DOI: 10.1186/s40608-017-0159-z.

References

Tack J, Talley N, Camilleri M, Holtmann G, Hu P, Malagelada J . Functional gastroduodenal disorders. Gastroenterology. 2006; 130(5):1466-79. DOI: 10.1053/j.gastro.2005.11.059. View

Clements R, Gonzalez Q, Foster A, Richards W, McDowell J, Bondora A . Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003; 13(4):610-4. DOI: 10.1381/096089203322190835. View

Santonicola A, Siniscalchi M, Capone P, Gallotta S, Ciacci C, Iovino P . Prevalence of functional dyspepsia and its subgroups in patients with eating disorders. World J Gastroenterol. 2012; 18(32):4379-85. PMC: 3436054. DOI: 10.3748/wjg.v18.i32.4379. View

Bianchini F, Kaaks R, Vainio H . Overweight, obesity, and cancer risk. Lancet Oncol. 2002; 3(9):565-74. DOI: 10.1016/s1470-2045(02)00849-5. View

Iovino P, Angrisani L, Galloro G, Consalvo D, Tremolaterra F, Pascariello A . Proximal stomach function in obesity with normal or abnormal oesophageal acid exposure. Neurogastroenterol Motil. 2006; 18(6):425-32. DOI: 10.1111/j.1365-2982.2006.00768.x. View

Cappello C, Tremolaterra F, Pascariello A, Ciacci C, Iovino P . A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life. Int J Colorectal Dis. 2012; 28(3):349-58. PMC: 3587687. DOI: 10.1007/s00384-012-1552-1. View

. Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. J Gastrointestin Liver Dis. 2007; 15(3):307-12. View

Eslick G . Gastrointestinal symptoms and obesity: a meta-analysis. Obes Rev. 2011; 13(5):469-79. DOI: 10.1111/j.1467-789X.2011.00969.x. View

Usai P, Manca R, Lai M, Russo L, Boi M, Ibba I . Prevalence of irritable bowel syndrome in Italian rural and urban areas. Eur J Intern Med. 2010; 21(4):324-6. DOI: 10.1016/j.ejim.2010.05.009. View

10.

Carabotti M, Silecchia G, Greco F, Leonetti F, Piretta L, Rengo M . Impact of laparoscopic sleeve gastrectomy on upper gastrointestinal symptoms. Obes Surg. 2013; 23(10):1551-7. DOI: 10.1007/s11695-013-0973-4. View

11.

Reaven G . Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am. 2011; 95(5):875-92. DOI: 10.1016/j.mcna.2011.06.002. View

12.

Flegal K, Graubard B, Williamson D, Gail M . Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005; 293(15):1861-7. DOI: 10.1001/jama.293.15.1861. View

13.

Delgado-Aros S, Cremonini F, Castillo J, Chial H, Burton D, Ferber I . Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology. 2004; 126(2):432-40. DOI: 10.1053/j.gastro.2003.11.007. View

14.

Fysekidis M, Bouchoucha M, Bihan H, Reach G, Benamouzig R, Catheline J . Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery. Obes Surg. 2011; 22(3):403-10. DOI: 10.1007/s11695-011-0396-z. View

15.

Delgado-Aros S, Richard Locke 3rd G, Camilleri M, Talley N, Fett S, Zinsmeister A . Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004; 99(9):1801-6. DOI: 10.1111/j.1572-0241.2004.30887.x. View

16.

Gallus S, Odone A, Lugo A, Bosetti C, Colombo P, Zuccaro P . Overweight and obesity prevalence and determinants in Italy: an update to 2010. Eur J Nutr. 2012; 52(2):677-85. DOI: 10.1007/s00394-012-0372-y. View

17.

Amato G, Limongelli P, Pascariello A, Rossetti G, Del Genio G, Del Genio A . Association between persistent symptoms and long-term quality of life after laparoscopic total fundoplication. Am J Surg. 2008; 196(4):582-6. DOI: 10.1016/j.amjsurg.2007.09.038. View

18.

Gallus S, Colombo P, Scarpino V, Zuccaro P, Negri E, Apolone G . Overweight and obesity in Italian adults 2004, and an overview of trends since 1983. Eur J Clin Nutr. 2006; 60(10):1174-9. DOI: 10.1038/sj.ejcn.1602433. View

19.

Sileri P, Franceschilli L, Cadeddu F, De Luca E, DUgo S, Tognoni V . Prevalence of defaecatory disorders in morbidly obese patients before and after bariatric surgery. J Gastrointest Surg. 2011; 16(1):62-6. DOI: 10.1007/s11605-011-1705-5. View

20.

Bray G . Health hazards of obesity. Endocrinol Metab Clin North Am. 1996; 25(4):907-19. DOI: 10.1016/s0889-8529(05)70361-3. View